![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: APBA1 |
Gene summary for APBA1 |
![]() |
Gene information | Species | Human | Gene symbol | APBA1 | Gene ID | 320 |
Gene name | amyloid beta precursor protein binding family A member 1 | |
Gene Alias | D9S411E | |
Cytomap | 9q21.12 | |
Gene Type | protein-coding | GO ID | GO:0001505 | UniProtAcc | Q02410 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
320 | APBA1 | NAFLD1 | Human | Liver | NAFLD | 6.22e-09 | 8.87e-01 | -0.04 |
320 | APBA1 | S41 | Human | Liver | Cirrhotic | 1.58e-02 | 5.32e-01 | -0.0343 |
320 | APBA1 | S43 | Human | Liver | Cirrhotic | 2.32e-05 | -1.94e-01 | -0.0187 |
320 | APBA1 | HCC1_Meng | Human | Liver | HCC | 6.94e-05 | -2.15e-01 | 0.0246 |
320 | APBA1 | HCC2_Meng | Human | Liver | HCC | 9.71e-06 | -2.17e-01 | 0.0107 |
320 | APBA1 | cirrhotic1 | Human | Liver | Cirrhotic | 3.90e-05 | -1.95e-01 | 0.0202 |
320 | APBA1 | cirrhotic2 | Human | Liver | Cirrhotic | 8.10e-04 | -2.05e-01 | 0.0201 |
320 | APBA1 | cirrhotic3 | Human | Liver | Cirrhotic | 3.98e-02 | -2.16e-01 | 0.0215 |
320 | APBA1 | HCC5 | Human | Liver | HCC | 4.04e-11 | -1.16e-01 | 0.4932 |
320 | APBA1 | Pt13.a | Human | Liver | HCC | 2.38e-05 | -2.15e-01 | 0.021 |
320 | APBA1 | Pt14.d | Human | Liver | HCC | 1.90e-03 | -2.02e-01 | 0.0143 |
320 | APBA1 | S016 | Human | Liver | HCC | 8.11e-03 | -2.20e-01 | 0.2243 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00352643 | Liver | NAFLD | multicellular organism growth | 27/1882 | 132/18723 | 2.57e-04 | 4.19e-03 | 27 |
GO:00307055 | Liver | NAFLD | cytoskeleton-dependent intracellular transport | 33/1882 | 195/18723 | 1.98e-03 | 1.98e-02 | 33 |
GO:00109703 | Liver | NAFLD | transport along microtubule | 26/1882 | 155/18723 | 6.30e-03 | 4.69e-02 | 26 |
GO:00080884 | Liver | NAFLD | axo-dendritic transport | 15/1882 | 75/18723 | 7.02e-03 | 4.91e-02 | 15 |
GO:00017015 | Liver | Cirrhotic | in utero embryonic development | 134/4634 | 367/18723 | 2.78e-07 | 6.86e-06 | 134 |
GO:003070511 | Liver | Cirrhotic | cytoskeleton-dependent intracellular transport | 68/4634 | 195/18723 | 9.54e-04 | 6.77e-03 | 68 |
GO:003526411 | Liver | Cirrhotic | multicellular organism growth | 47/4634 | 132/18723 | 3.40e-03 | 1.89e-02 | 47 |
GO:000808811 | Liver | Cirrhotic | axo-dendritic transport | 29/4634 | 75/18723 | 5.24e-03 | 2.69e-02 | 29 |
GO:00109701 | Liver | Cirrhotic | transport along microtubule | 52/4634 | 155/18723 | 8.42e-03 | 3.91e-02 | 52 |
GO:000170111 | Liver | HCC | in utero embryonic development | 204/7958 | 367/18723 | 2.44e-07 | 4.30e-06 | 204 |
GO:00080882 | Liver | HCC | axo-dendritic transport | 52/7958 | 75/18723 | 2.34e-06 | 3.14e-05 | 52 |
GO:003070521 | Liver | HCC | cytoskeleton-dependent intracellular transport | 111/7958 | 195/18723 | 3.25e-05 | 3.28e-04 | 111 |
GO:00109702 | Liver | HCC | transport along microtubule | 90/7958 | 155/18723 | 6.49e-05 | 5.92e-04 | 90 |
GO:003526421 | Liver | HCC | multicellular organism growth | 70/7958 | 132/18723 | 9.29e-03 | 3.57e-02 | 70 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
APBA1 | SNV | Missense_Mutation | novel | c.2190N>T | p.Lys730Asn | p.K730N | Q02410 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | rs769199164 | c.1870N>A | p.Glu624Lys | p.E624K | Q02410 | protein_coding | deleterious(0.02) | probably_damaging(0.98) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | c.1993G>C | p.Glu665Gln | p.E665Q | Q02410 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AG-A02X-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
APBA1 | SNV | Missense_Mutation | rs751164226 | c.1771N>A | p.Val591Ile | p.V591I | Q02410 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | novel | c.2501N>T | p.Pro834Leu | p.P834L | Q02410 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | rs367760423 | c.1445N>A | p.Arg482His | p.R482H | Q02410 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | novel | c.1222N>C | p.Ser408Pro | p.S408P | Q02410 | protein_coding | tolerated(0.09) | benign(0.001) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | rs201072152 | c.1009N>T | p.Arg337Trp | p.R337W | Q02410 | protein_coding | deleterious_low_confidence(0) | benign(0) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | rs766705353 | c.1678N>T | p.Arg560Cys | p.R560C | Q02410 | protein_coding | deleterious(0) | benign(0.27) | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
APBA1 | SNV | Missense_Mutation | rs766705353 | c.1678N>T | p.Arg560Cys | p.R560C | Q02410 | protein_coding | deleterious(0) | benign(0.27) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
320 | APBA1 | NA | HESPERIDIN | HESPERIDIN | ||
320 | APBA1 | NA | PHENAZINE-2,3-DIAMINE | CHEMBL274921 | ||
320 | APBA1 | NA | GNF-PF-3464 | CHEMBL602213 | ||
320 | APBA1 | NA | NSC-50654 | CHEMBL1372046 | ||
320 | APBA1 | NA | TCMDC-125221 | CHEMBL546649 | ||
320 | APBA1 | NA | BENZO[D]ISOTHIAZOL-3-ONE | CHEMBL297304 | ||
320 | APBA1 | NA | NSC-180246 | CHEMBL484640 | ||
320 | APBA1 | NA | NIFEDIPINE | NIFEDIPINE | ||
320 | APBA1 | NA | SLAZINIC ACID | SLAZINIC ACID |
Page: 1 |